Saakshi Medtech & Panels Ltd (SAAKSHI) Announcements - Latest Exchange Filings with AI Summaries
Latest corporate announcements filed by Saakshi Medtech & Panels Ltd on NSE and BSE, with an AI summary of each filing.
Saakshi Medtech and Panels Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on September 30, 2026. Further, the company has informed the Exchange regarding voting results.
Annual General Meeting · 03 Oct 2026, 9:05 pm
Saakshi Medtech and Panels Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on September 30, 2026
Annual General Meeting · 30 Sept 2026, 10:18 pm
Saakshi Medtech and Panels Limited has informed the Exchange regarding Appointment of Mr Nandkumar Vasant Dhekne as Independent Director of the company w.e.f. August 19, 2026.
Change in Management · 16 Sept 2026, 1:56 am
Saakshi Medtech Appoints Nandkumar Dhekne and Ravi Vartak to Board Saakshi Medtech and Panels Limited submitted a revised disclosure regarding the appointment of two Additional Directors, effective 19th Aug'26 for a 3-year term, subject to shareholder approval. Nandkumar Vasant Dhekne joins as an Independent Director, bringing ~40 years of experience across specialty chemicals, energy, and leadership at GE. Additionally, Ravi Madhav Vartak, who has served as Operations Manager since Dec'18, has been appointed as Whole-time Director (Executive Director). Both appointees hold no familial relations to existing directors and face no regulatory debarments.
Saakshi Medtech and Panels Limited has received In - Principle approval for listing of 2010259 Equity shares of Rs. 10/- each allotted on preferential basis.
Others (Uncategorized) · 12 Sept 2026, 10:18 pm
Saakshi Medtech Secures NSE In-Principle Approval for Preferential Share Listing Saakshi Medtech and Panels Limited received in-principle approval from the NSE on 11th Sep'26 to list 2,010,259 equity shares (face value Rs. 10 each). The shares were allotted on a preferential basis for consideration other than cash under a share swap transaction with Laxmi Engineering Industries Bhopal Pvt Ltd. Trading admission remains subject to final depository confirmation from NSDL/CDSL regarding beneficiary account credits.
Saakshi Medtech and Panels Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on September 30, 2026
Annual General Meeting · 08 Sept 2026, 10:33 pm
Saakshi Medtech and Panels Limited has informed the Exchange regarding Re-Appointment of Mr Aniket Vijay Latkar as Chairman & Managing Director of the company w.e.f. Jun 08, 2026.
Change in Management · 07 Sept 2026, 11:38 pm
Saakshi Medtech Approves Re-Appointment of CMD Aniket Latkar for Five Years The Board of Directors of Saakshi Medtech and Panels Limited, at its meeting on 7th Sep'26, approved the re-appointment of Mr. Aniket Vijay Latkar as Chairman and Managing Director for a further period of five years, effective from 8th Jun'26. Mr. Latkar brings over 15 years of industry experience across manufacturing, engineering, R&D, and business management functions.
Saakshi Medtech and Panels Limited has informed the Exchange regarding Outcome of Board Meeting held on August 21, 2026 regarding approval and allotment of Equity shares on preferential basis.
Outcome · 21 Aug 2026, 10:22 pm
Saakshi Medtech Approves Preferential Allotment for Share Swap On 21-Aug-26, Saakshi Medtech's board approved a preferential allotment of 2,010,259 equity shares to non-promoters. The issue price is set at Rs. 207 per share, valuing the total transaction at Rs. 41.61 Cr. This issuance is for a non-cash consideration, specifically a swap of shares. The allotment involves multiple entities and individuals, including Saraf Investments and Snehal Bhupendra Shah, in exchange for shares of a target company.
Saakshi Medtech and Panels Limited has informed the Exchange regarding Appointment of Mr . Nandkumar Vasant Dhekne as Independent Director of the company w.e.f. August 19, 2026.
Change in Management · 19 Aug 2026, 10:47 pm
Saakshi Medtech Appoints New Independent and Whole-Time Directors Saakshi Medtech has appointed Mr. Nandkumar Vasant Dhekne as an Independent Director and Mr. Ravi Mahadev Vartak as a Whole-Time Director, effective 19th Aug'26. Both appointments are for three-year terms, pending shareholder approval. Mr. Dhekne brings 40 years of experience, including CEO-level roles at global firms like GE, with expertise in specialty chemicals and energy. Mr. Vartak has over three decades of experience in procurement and operations and has served as the company's Operations Manager since Dec'18.
SAAKSHI: Saakshi Medtech and Panels Limited has informed the Exchange regarding the receipt of In-Principle Approval from NSE for the proposed preferential issue.
Others (Uncategorized) · 07 Aug 2026, 5:50 pm
Saakshi Medtech Receives NSE Nod for Preferential Share Issue in Acquisition Saakshi Medtech has received in-principle approval from the NSE on 06 Aug'26 for a preferential issue of 2,022,940 equity shares. The shares, priced at Rs. 207 each, will be issued as consideration for a share swap transaction to acquire Laxmi Engineering Industries Bhopal Pvt Ltd. This non-cash deal enables the company to issue new equity to the promoters of the target company. The regulatory approval is valid for fifteen days from the date of the NSE's approval letter.
Saakshi Medtech and Panels Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
Others (Uncategorized) · 18 Jul 2026, 12:06 am
Saakshi Medtech Confirms No Rematerialisation Requests for Q1 FY27 Saakshi Medtech and Panels filed its certificate under SEBI DP Regulations for the quarter ended 30th Jun'26. The company's Registrar, Bigshare Services, confirmed that Regulation 74(5) is not applicable as the entire shareholding is in dematerialized form. Consequently, no requests for rematerialisation or dematerialisation were received or processed during the quarter. This indicates a fully digitized shareholding structure with no activity in physical share conversions.
Saakshi Medtech and Panels Limited has informed the Exchange about General Updates regarding updated valuation report in connection of Preferential Issue.
Others (Uncategorized) · 17 Jul 2026, 11:35 pm
Saakshi Medtech Discloses Updated Valuation for Preferential Issue On 17 Jul'26, Saakshi Medtech announced receipt of an updated valuation report concerning its preferential issue of equity shares on a non-cash basis. The issue was previously approved by shareholders on 2 Jun'26. The new valuation, based on the latest audited financials, confirms the fair value of assets to be acquired. Importantly, the company stated that the updated report does not materially alter the terms of the preferential issue, and there is no change to the swap ratio or issue price.
Structural Digital Database
Others (Uncategorized) · 29 Jun 2026, 11:37 pm
Saakshi Medtech Files Insider Trading Compliance Certificate Saakshi Medtech and Panels submitted its Structured Digital Database (SDD) compliance certificate on 26th Jun'26, as required by SEBI's Insider Trading regulations. The certificate, issued by Aditya Patil & Co., covers the period from 01st Apr'26 to 26th Jun'26. It confirms the company maintains a non-tamperable, internally-managed database with an audit trail to record Unpublished Price Sensitive Information (UPSI). The filing reported NIL non-compliances for the previous quarter, indicating adherence to regulatory requirements for managing UPSI dissemination.